Vertex Pharmaceuticals Incorporated
Daniel J. Brennan (Director) reports VRTX insider transactions
About this filing
Vertex Pharmaceuticals Incorporated (VRTX) filed Form 3 (initial insider holdings) with the SEC on Oct 22, 2026.
Key facts
- Insider
- Daniel J. Brennan · Director
No transactions reported; holdings only.
Remarks: Exhibit 24 - Power of Attorney
More VRTX filings
- 4
Filed Oct 22, 2026
- 8-K
Filed Oct 20, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Oct 19, 2026
- 4
Filed Sep 10, 2026
- 3
Filed Sep 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.